Literature DB >> 21089702

The efficacy of chemical adjuvants on giant-cell tumour of bone. An in vitro study.

Y Gortzak1, R Kandel, B Deheshi, J Werier, R E Turcotte, P C Ferguson, J S Wunder.   

Abstract

Various chemicals are commonly used as adjuvant treatment to surgery for giant-cell tumour (GCT) of bone. The comparative effect of these solutions on the cells of GCT is not known. In this study we evaluated the cytotoxic effect of sterile water, 95% ethanol, 5% phenol, 3% hydrogen peroxide (H(2)O(2)) and 50% zinc chloride (ZnCI(2)) on GCT monolayer tumour cultures which were established from six patients. The DNA content, the metabolic activity and the viability of the cultured samples of tumour cells were assessed at various times up to 120 hours after their exposure to these solutions. Equal cytotoxicity to the GCT monolayer culture was observed for 95% ethanol, 5% phenol, 3% H(2)O(2) and 50% ZnCI(2). The treated samples showed significant reductions in DNA content and metabolic activity 24 hours after treatment and this was sustained for up to 120 hours. The samples treated with sterile water showed an initial decline in DNA content and viability 24 hours after treatment, but the surviving cells were viable and had proliferated. No multinucleated cell formation was seen in these cultures. These results suggest that the use of chemical adjuvants other than water could help improve local control in the treatment of GCT of bone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21089702     DOI: 10.1302/0301-620x.92b10.23495

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  17 in total

1.  Similar local control between phenol- and ethanol-treated giant cell tumors of bone.

Authors:  Wei-Hsin Lin; Tsung-Yu Lan; Chih-Yu Chen; Karl Wu; Rong-Sen Yang
Journal:  Clin Orthop Relat Res       Date:  2011-07-06       Impact factor: 4.176

2.  Giant cell tumors of the sacrum--a nationwide study on midterm results in 26 patients after intralesional excision.

Authors:  L van der Heijden; M A J van de Sande; I C M van der Geest; H W B Schreuder; B J van Royen; P C Jutte; J A M Bramer; F C Öner; A P van Noort-Suijdendorp; H M Kroon; P D S Dijkstra
Journal:  Eur Spine J       Date:  2014-03-11       Impact factor: 3.134

3.  Percutaneous radiofrequency ablation for treatment of giant cell tumor of bone guided by real-time US fused with CT.

Authors:  Qiyu Zhao; Lifeng Wang; Fen Chen; Tian-An Jiang
Journal:  J Med Ultrason (2001)       Date:  2013-07-24       Impact factor: 1.314

Review 4.  The clinical approach toward giant cell tumor of bone.

Authors:  Lizz van der Heijden; P D Sander Dijkstra; Michiel A J van de Sande; Judith R Kroep; Remi A Nout; Carla S P van Rijswijk; Judith V M G Bovée; Pancras C W Hogendoorn; Hans Gelderblom
Journal:  Oncologist       Date:  2014-04-09

5.  Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.

Authors:  Noritaka Yonezawa; Hideki Murakami; Satoshi Kato; Akihiko Takeuchi; Hiroyuki Tsuchiya
Journal:  Eur Spine J       Date:  2017-04-10       Impact factor: 3.134

6.  Fifty years of bone tumors.

Authors:  Meredith K Bartelstein; Patrick J Boland
Journal:  J Surg Oncol       Date:  2022-10       Impact factor: 2.885

7.  Mid-term results of intralesional extended curettage, cauterization, and polymethylmethacrylate cementation in the treatment of giant cell tumor of bone: A retrospective case series.

Authors:  Evrim Şirin; Ahmet Hamdi Akgülle; Osman Mert Topkar; Ömer Sofulu; Said Erkam Baykan; Bülent Erol
Journal:  Acta Orthop Traumatol Turc       Date:  2020-09       Impact factor: 1.511

Review 8.  Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor.

Authors:  Yuhree Kim; Saqib Nizami; Hana Goto; Francis Y Lee
Journal:  Clin Orthop Surg       Date:  2012-05-17

9.  Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.

Authors:  Piotr Rutkowski; Stefano Ferrari; Robert J Grimer; Paul D Stalley; Sander P D Dijkstra; Andrzej Pienkowski; Gualter Vaz; Jay S Wunder; Leanne L Seeger; Amy Feng; Zachary J Roberts; Bruce A Bach
Journal:  Ann Surg Oncol       Date:  2015-06-02       Impact factor: 5.344

Review 10.  Contemporary adjuvant polymethyl methacrylate cementation optimally limits recurrence in primary giant cell tumor of bone patients compared to bone grafting: a systematic review and meta-analysis.

Authors:  Dongqing Zuo; Longpo Zheng; Wei Sun; Dong Fu; Yingqi Hua; Zhengdong Cai
Journal:  World J Surg Oncol       Date:  2013-07-16       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.